Efficacy of dapagliflozin plus saxagliptin vs insulin glargine at 52 weeks in patients with type 2 diabetes inadequately controlled by metformin with or without sulfonylurea

被引：0

作者：

Vilsboll, T. ^{[1
]}

Ekholm, E. ^{[2
]}

Johnsson, E. ^{[2
]}

Garcia-Sanchez, R. ^{[3
]}

Dronamraju, N. ^{[3
]}

Jabbour, S. A. ^{[4
]}

Lind, M. ^{[5
]}

机构：

[1] Steno Diabet Ctr, Copenhagen, Denmark

[2] AstraZeneca, Molndal, Sweden

[3] AstraZeneca, Gaithersburg, MD USA

[4] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[5] Univ Gothenburg, Gothenburg, Sweden

来源：

DIABETOLOGIA | 2018年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

775

引用

页码：S380 / S380

页数：1

共 50 条

[41] Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study
Hong, Jun Hwa
Moon, Jun Sung
Seong, Kayeon
Lim, Soo
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 203
[42] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
Magner, J
Taylor, T
Krol, A
Rosenstock, J
[J]. DIABETOLOGIA, 1998, 41 : A231 - A231
[43] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
Rosenstock, J
Magner, J
Krol, A
Taylor, T
[J]. DIABETES, 1998, 47 : A351 - A351
[44] Basal/bolus with prandial inhaled Technosphere insulin plus insulin glargine vs biaspart 70/30 insulin in type 2 diabetes inadequately controlled on insulin with/without oral agents
Gnudi, L.
Lorber, D.
Rosenstock, J.
Howard, C.
Petrucci, R.
Shearer, D.
Bilheimer, D.
Chang, P. -C.
Richardson, P.
[J]. DIABETOLOGIA, 2009, 52 : S360 - S360
[45] Efficacy and safety of dapagliflozin in patients with type 2 diabetes on insulin ± metformin regimens
Yeh, H.
Katz, A.
[J]. DIABETOLOGIA, 2015, 58 : S357 - S357
[46] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes on Insulin ± Metformin Regimens
Katz, Arie
Yeh, Helen
[J]. DIABETES, 2015, 64 : A317 - A317
[47] Efficacy and Safety of Once-Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and/or a Sulfonylurea in Predominantly Asian Patients with Type 2 Diabetes
Wang, Weiqing
Ruiz, Luis Nevarez
Filippova, Ekaterina
Song, Ki-Ho
Gu, Liqun
Li, Pengfei
Yang, Jun
[J]. DIABETES, 2015, 64 : A74 - A74
[48] Efficacy of glyburide/metformin tablets versus metformin plus rosiglitazone in patients with Type 2 diabetes inadequately controlled with metformin monotherapy.
Mohideen, P
Klein, E
Bruce, S
[J]. DIABETOLOGIA, 2002, 45 : A242 - A242
[49] Benefits of a fixed-ratio formulation of once-daily insulin glargine/lixisenatide (LixiLan) vs glargine in type 2 diabetes inadequately controlled on metformin
Rosenstock, J.
Diamant, M.
Silvestre, L.
Souhami, E.
Zhou, T.
Fonseca, V.
[J]. DIABETOLOGIA, 2014, 57 : S108 - S108
[50] Linagliptin Improves Glycemic Control in Type 2 Diabetes Patients Inadequately Controlled by Metformin and Sulfonylurea without Weight Gain or Hypoglycemia
Owens, David R.
Swallow, Ros
Jones, Peter
Dugi, Klaus A.
Woerle, Hans-Juergen
[J]. DIABETES, 2010, 59 : A149 - A149

← 1 2 3 4 5 →